Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.

Saved in:
Bibliographic Details
Title: Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.
Authors: Jang H; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Shin D; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Park B; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Lee JH; Department of Applied Life Science, BK21 Program, Konkuk University, Chungju, Republic of Korea., Ryu Y; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Lee J; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Ko E; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea., Ko YS; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Lee HY; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Choi YE; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Oh SW; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Jo SK; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Lee S; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea., Park J; Department of Applied Life Science, BK21 Program, Konkuk University, Chungju, Republic of Korea., Kim K; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Kim SH; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea. sunkim@kist.re.kr.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. sunkim@kist.re.kr., Kim MG; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea. gyu219@hanmail.net., Yang Y; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea. yangys@skku.edu., Shim MK; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. mks@kist.re.kr.
Source: Journal of nanobiotechnology [J Nanobiotechnology] 2026 Apr 10; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-3155
DOI:10.1186/s12951-026-04357-7